Pursuant to Decision No. 13/375/17.3.2006 of the Capital Market Commission, ALAPIS S.A. announces to its investors that following the increase of the company's share capital, due to the merger of ALAPIS S.A. (ex VETERIN S.A.) with the companies LAMDA DETERGENT S.A., EBIK S.A. (both listed on the Athens Stock Exchange) and ELPHARMA S.A, (not listed on the Athens Stock Exchange), pursuant to the decisions of the Extraordinary General Shareholders Meetings of the above merged companies and approval Decision No. K2-7289/24-05-07 of the Ministry of Development, during the listing of the new shares, which resulted from the merger, on the Athens Stock Exchange on 1 June 2007, a balance of fractional shares was created. The parties entitled to fractional shares corresponding to:
* 2,827,79 ALAPIS S.A. (ex VETERIN S.A.) shares,
* 639,06 LAMDA DETERGENT S.A. shares, and
* 309,14 EBIK S.A. shares, are the company shareholders who are registered in the respective records of the Hellenic Exchanges group (HELEX).
Therefore, the above shareholders and owners of fractional shares, according to the provisions of paragraph 2, Article 44a, which was added to Law 2396/1996 via paragraph 1, Article 53 of Law 3371/2005, are invited to sell or acquire the remaining fractional shares in order to form whole shares, by 1st December 2007, which marks the expiration of the six-month deadline from the aforementioned listing of the shares that resulted from the merger.
If no action is taken within the above six-month deadline, the fractional shares will be sold through the Athens Stock Exchange, according to article 99 of the Regulation of ATHEX, under the supervision of the Company, and following a relevant announcement by the latter, the sale proceeds will be returned to the shareholders who are entitled to them. For any further information, Shareholders may contact the Company's Investor Relations Department, during regular business hours, on tel.: 213-0175056.